India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Alembic Pharmaceuticals Ltd.

Income Statement - Consolidated

Market Cap.(`)	22843.58 Cr.	P/BV	4.74	Book Value (`)	245.12
52 Week High/Low ( ` )	1304/707	FV/ML	2/1	P/E(X)	37.09
Book Closure	15/07/2024	EPS (`)	31.33	Div Yield (%)	0.95

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00


INCOME
Revenue From Operations [Net]	6112.11	5499.77	5231.79	5276.22	4491.97
Other Operating Revenues	116.51	152.85	74.00	116.91	113.78
Total Operating Revenues	6228.62	5652.62	5305.79	5393.13	4605.75

Other Income	28.31	2.74	50.46	10.02	4.94
Total Revenue	6256.93	5655.36	5356.25	5403.15	4610.69

EXPENSES
Cost Of Materials Consumed	1403.01	1250.08	1129.11	1185.35	979.05
Purchase Of Stock-In Trade	454.91	380.09	360.50	265.92	270.93
Operating And Direct Expenses	0.00	50.90	0.00	22.39	17.56
Changes In Inventories Of FG,WIP And Stock-In Trade	-142.84	78.65	-43.19	-193.93	-210.59
Employee Benefit Expenses	1446.29	1169.13	1133.00	1051.17	906.44
Finance Costs	56.19	50.17	17.73	16.02	27.16
Depreciation And Amortisation Expenses	272.67	275.43	286.78	183.47	157.32
Other Expenses	2133.90	2015.39	1852.21	1504.68	1419.34
Total Expenses	5624.13	5269.84	4736.14	4035.07	3567.21

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	632.80	385.52	620.11	1368.08	1043.48

Exceptional Items	0.00	0.00	0.00	0.00	-43.65
Profit/Loss Before Tax	632.80	385.52	620.11	1368.08	999.83

Tax Expenses-Continued Operations
Current Tax	65.81	4.20	129.18	255.47	204.57
Deferred Tax	-46.06	9.20	-23.47	-9.56	-4.30
Tax For Earlier Years	-3.75	-0.79	-1.25	7.41	-1.09
Total Tax Expenses	16.00	12.61	104.46	253.32	199.18
Profit/Loss After Tax And Before ExtraOrdinary Items	616.80	372.91	515.65	1114.76	800.65

Profit/Loss From Continuing Operations	616.80	372.91	515.65	1114.76	800.65

Profit/Loss For The Period	616.80	372.91	515.65	1114.76	800.65

Minority Interest	0.00	0.00	0.00	31.61	28.12
Share Of Profit/Loss Of Associates	-0.98	-30.92	5.29	31.74	0.05
Consolidated Profit/Loss After MI And Associates	615.82	341.99	520.94	1178.11	828.82

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	31.33	17.40	26.50	60.81	43.97
Diluted EPS (Rs.)	31.33	17.40	26.50	60.81	43.97

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	157.25	196.56	275.19	0.00	325.97

Alembic Pharmaceuticals Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	22843.58 Cr.	P/BV	4.74	Book Value (`)	245.12
52 Week High/Low ( ` )	1304/707	FV/ML	2/1	P/E(X)	37.09
Book Closure	15/07/2024	EPS (`)	31.33	Div Yield (%)	0.95

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1965.63	1965.63	1965.63	1965.63	1885.16

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31	39.31	39.31	39.31	37.70
Total Share Capital	39.31	39.31	39.31	39.31	37.70

Reserves and Surplus	4778.89	4331.16	5198.23	5088.30	3181.71
Total Reserves and Surplus	4778.89	4331.16	5198.23	5088.30	3181.71
Total Shareholders Funds	4818.20	4370.47	5237.54	5127.61	3219.41
Minority Interest	0.00	0.00	0.00	-60.64	-28.96

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	199.89	886.99
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	4.21	12.19
Other Long Term Liabilities	62.88	69.23	72.14	71.54	73.30
Long Term Provisions	109.51	106.20	95.82	85.52	74.51
Total Non-Current Liabilities	172.39	175.43	167.96	361.16	1046.99

CURRENT LIABILITIES
Short Term Borrowings	430.45	635.87	629.99	0.02	860.50
Trade Payables	735.64	679.81	706.39	668.77	625.93
Other Current Liabilities	223.65	251.19	316.51	560.07	226.98
Short Term Provisions	65.25	70.06	63.64	51.99	38.19
Total Current Liabilities	1454.99	1636.93	1716.53	1280.85	1751.60

Total Capital And Liabilities	6445.58	6182.83	7122.03	6708.98	5989.04

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2546.71	2398.45	1741.47	1703.74	1524.90
Intangible Assets	0.00	0.00	56.38	85.55	26.94
Capital Work-In-Progress	524.36	601.28	2205.79	1944.28	1574.10
Intangible Assets Under Development	0.00	0.00	98.44	237.39	272.08
Fixed Assets	3071.07	2999.73	4102.08	3970.96	3398.02
Non-Current Investments	93.02	96.33	118.40	49.31	17.62
Deferred Tax Assets [Net]	169.64	123.01	5.88	0.00	0.00
Other Non-Current Assets	33.29	53.74	34.88	110.81	110.66
Total Non-Current Assets	3367.02	3272.81	4261.24	4131.08	3526.30


CURRENT ASSETS
Current Investments	0.00	0.00	0.00	186.97	0.00
Inventories	1643.54	1475.27	1609.70	1486.15	1187.53
Trade Receivables	1024.84	1046.40	807.13	348.58	864.75
Cash And Cash Equivalents	126.57	82.27	69.43	105.84	80.75
OtherCurrentAssets	283.61	306.08	374.53	450.36	329.71
Total Current Assets	3078.56	2910.02	2860.79	2577.90	2462.74

Total Assets	6445.58	6182.83	7122.03	6708.98	5989.04

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	183.13	317.96	228.15	349.23	386.98

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	68.61	71.20	63.69	0.45	0.45

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Alembic Pharmaceuticals Ltd.

Income Statement - Consolidated

Alembic Pharmaceuticals Ltd.

Balance Sheet - Consolidated